Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
ANTI-IGF-1R ANTIBODY AND APPLICATIONS THEREOF
Document Type and Number:
WIPO Patent Application WO/2021/203861
Kind Code:
A1
Abstract:
Provided in the present invention is an antibody that can bind to IGF-1R. The present antibody is made up of light chains and heavy chains, and light chain and heavy chain variable domains thereof are one selection among the groups SEQ ID NO: 2 and SEQ ID NO: 3, SEQ ID NO: 4 and SEQ ID NO: 5, SEQ ID NO: 6 and SEQ ID: NO 7, SEQ ID NO: 8 and SEQ ID NO: 9, SEQ ID NO: 10 and SEQ ID NO: 11, SEQ ID NO: 12 and SEQ ID NO: 13, and SEQ ID NO: 14 and SEQ ID NO: 15. Further provided in the present invention are a nucleic acid molecule coding the antibody that binds to IGF-1R, a vector including the nucleic acid, a host cell transformed by said vector, and applications of the nucleic acid, the vector, and the host cell.

Inventors:
GUO SHUHUA (CN)
MA LIN (CN)
ZHANG PENG (CN)
Application Number:
PCT/CN2021/077939
Publication Date:
October 14, 2021
Filing Date:
February 25, 2021
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
SUZHOU PRO HEAL PHARMACEUTICALS TECH CO LTD (CN)
International Classes:
C07K16/28; A61K39/395; A61P27/02; C12N5/10; C12N15/13; C12N15/63
Domestic Patent References:
WO2019136405A12019-07-11
WO2004087756A22004-10-14
Foreign References:
CN102725000A2012-10-10
CN102123712A2011-07-13
CN109803679A2019-05-24
US20100158919A12010-06-24
US20140193404A12014-07-10
CN200880011970A2008-02-12
CN200880114015A2008-08-28
CN200780011979A2007-03-28
CN200980137723A2009-09-21
US20190040141A12019-02-07
US20090175868A12009-07-09
US20060018910A12006-01-26
Other References:
AMY PATEL ET AL.: "A New Era in the Treatment of Thyroid Eye Disease", AMERICAN JOURNAL OF OPHTHALMOLOGY., vol. 208, 1 August 2019 (2019-08-01), XP085928883, DOI: 10.1016/j.ajo.2019.07.021
See also references of EP 4134380A4
Attorney, Agent or Firm:
JJS INTELLECTUAL PROPERTY AGENCY LTD. (CN)
Download PDF: